IRIS
LUS, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.742
NA - Nord America 5.105
AS - Asia 3.908
SA - Sud America 658
AF - Africa 53
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.475
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 6.333
US - Stati Uniti d'America 4.994
SG - Singapore 1.430
IE - Irlanda 956
CN - Cina 848
IT - Italia 619
HK - Hong Kong 570
BR - Brasile 568
VN - Vietnam 514
UA - Ucraina 429
GB - Regno Unito 412
DE - Germania 349
FR - Francia 168
KR - Corea 155
FI - Finlandia 128
IN - India 97
SE - Svezia 95
TR - Turchia 76
GR - Grecia 69
JP - Giappone 54
CA - Canada 50
AR - Argentina 45
MX - Messico 40
BD - Bangladesh 32
BE - Belgio 29
NL - Olanda 29
IQ - Iraq 25
HU - Ungheria 22
PL - Polonia 22
AT - Austria 21
IR - Iran 20
ID - Indonesia 16
ZA - Sudafrica 13
ES - Italia 12
PK - Pakistan 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
MA - Marocco 10
CH - Svizzera 9
TN - Tunisia 9
CO - Colombia 8
AE - Emirati Arabi Uniti 7
VE - Venezuela 7
EG - Egitto 6
LT - Lituania 6
CL - Cile 5
IL - Israele 5
PH - Filippine 5
RS - Serbia 5
SA - Arabia Saudita 5
UY - Uruguay 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
TH - Thailandia 3
TW - Taiwan 3
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
KG - Kirghizistan 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GP - Guadalupe 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
RO - Romania 1
SI - Slovenia 1
Totale 19.470
Salva come PNG Salva come JPEG
Città #
Moscow 2.274
Dublin 955
Santa Clara 645
Singapore 621
Jacksonville 597
Chandler 578
Hong Kong 556
San Jose 530
Ashburn 236
Ho Chi Minh City 167
Seoul 152
Beijing 148
Ann Arbor 146
Princeton 143
Hefei 133
Hanoi 114
Roxbury 112
Dallas 105
Medford 99
Bremen 96
Naples 96
Caserta 88
New York 87
The Dalles 70
Boardman 68
Munich 64
Wilmington 59
Woodbridge 57
Los Angeles 56
Cambridge 51
Bengaluru 50
São Paulo 50
Memphis 39
San Mateo 39
Milan 31
Brussels 27
Da Nang 26
Norwalk 24
Nuremberg 24
Aversa 22
Des Moines 22
Houston 22
Haiphong 21
Amsterdam 20
Helsinki 19
Rio de Janeiro 19
Jinan 18
Toronto 18
Rome 17
Warsaw 16
Belo Horizonte 14
Chennai 14
Chicago 14
Dong Ket 14
Nanjing 14
Tianjin 14
Turku 14
Atlanta 13
Frankfurt am Main 13
Stockholm 13
Orem 12
Phoenix 12
Tokyo 12
Guarulhos 11
Ninh Bình 11
Porto Alegre 11
Redwood City 11
San Francisco 11
Council Bluffs 10
Curitiba 10
Falkenstein 10
Luzzano 10
Mexico City 10
Montreal 10
Mountain View 10
Thái Bình 10
Vienna 10
Baghdad 9
Düsseldorf 9
Seattle 9
Auburn Hills 8
Biên Hòa 8
Brasília 8
Bắc Ninh 8
Can Tho 8
Columbus 8
Joinville 8
Miami 8
Phú Nhuận 8
Siano 8
Boston 7
Casablanca 7
Cuiabá 7
Guangzhou 7
London 7
Napoli 7
Philadelphia 7
Taizhou 7
Zhengzhou 7
Ankara 6
Totale 10.121
Salva come PNG Salva come JPEG
Nome #
INSOLITO PNEUMOCEFALO IPERTESO DA OSTEOMA DEL SENO FRONTALE 229
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 203
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 201
Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro 182
A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations 178
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate 176
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 165
Chronic HCV infection and neurological and psychiatric disorders: an overview. 164
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 160
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 157
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 155
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients 154
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis 154
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 154
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis 152
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 152
A new tRNAHis mutation in the mtDNA results in mitochondrial encephalomyopathy by hampering ATP production 150
Analisi in istofluorescenza di densità e distribuzione dei recettori per ConA e WGA in corso di rigenerazione e re-innervazione nel muscolo scheletrico di ratto ischemizzato e denervato, reversibilmente o irreversibilmente 149
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 148
Biochemical and morphological evidences supporting the hypothesis of a role of Tgase in the pathogeneisi of Chorea-Acanthocytosis 148
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 147
[Ambulatory monitoring of arterial pressure in the diagnosis and therapeutic evaluation of dysautonomic diseases: observations in a case of Shy-Drager syndrome] 144
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 144
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis 143
A cluster of progranulin C157KfsX97 mutation in southern Italy- clinical characterization and genetic correlations 142
Rasagiline improves sleep disorders in Parkinson's disease 141
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 140
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 140
[Unusual histo-cytopathologic findings in a familial case of stiff spine syndrome] 139
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches 138
Malattie dei nervi periferici 138
Myopathic changes in neurofibromatosis type 1 138
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 138
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 138
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis 137
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 136
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 136
An unusual phenotype of familial motor and sensory neuropathy with morphological features of HMSN1 135
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 135
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 135
Myoplasticity and myoregeneration; from molecular aspects to clinical perspectives 133
39. Density and distribution of ConA and WGA receptors determined by histofluorescence analysis during degeneration, regeneration and reinnervation of the rat skeletal muscle following ischemia and reversible or irreversible denervation. , : , 133
CTG repeat number in the nonaffected allele of myotonic dystrophy patients is not critical for disease expression 131
Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 129
Disability assessment using Google Maps 129
A real-world study of alemtuzumab in a cohort of Italian patients 129
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 128
Cecità e diplopia come espressione isolata di metastasi mesencefalica:considerazioni neuroradiologiche neurologiche e neurochirurgiche.A proposito di 2 casi 128
NEURO-DEGENERAZIONE CON ACCUMULO CEREBRALE DI FERRO TIPO 1 (NIBA TIPO1), UNA NUOVA FAMIGLIA CON MALATTIA DI HALLERVORDEN SPATZ A DECORSO CLINICO PROTRATTO 128
Signs and symptoms of COVID-19 in patients with multiple sclerosis 127
Therapeutic Plasmapheresis: a revision of literature 126
Unusual manifestation of vertebral osteoid osteoma: case report 126
CECITÀ E DIPLOPIA COME ESPRESSIONE ISOLATA DI METASTASI MESENCEFALICHE: CONSIDERAZIONI NEURORADIOLOGICHE, NEUROLOGICHE E NEUROCHIRURGICHE A PROPOSITO DI DUE CASI” 125
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 125
Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment. 124
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 123
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 122
Retrospective epidemiology of Duchenne muscular dystrophy in Molise 122
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 122
Reperti isto e citopatologici del tutto peculiari riscontrati in un caso familiare di sindrome della spina rigida 121
LA NEUROMIELITE OTTICA È UN’ ASSOCIAZIONE SINDROMICA COMUNE A PATOLOGIE ETEROGENEE 121
C’È UN GUADAGNO DIAGNOSTICO IN RM DELLE SACNSIONI TARDIVE OPO DOSE TRIPLA DI GADOLINIO NELL’IDENTIFICAZIONE DI PLACCHE ATTIVE DI SCLEROSI MULTIPLA? * Risultati preliminari 120
Clinical and Genetic Heterogeneity in a Large Family with Pseudoxanthoma Elasticum: MTHFR and SERPINE1 Variants as Possible Disease Modifiers in Developing Ischemic Stroke 120
Long-term effects of asymmetrical posture in boxing assessed by baropodometry 119
CORRELATI CLINICO-STRUMENTALI IN UN CASO DI CREUTZFELD- JACOB A LUNGA SOPRAVVIVENZA. 118
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 117
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 117
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response 117
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 116
Fluctuations of MS births and UV-light exposure. 116
Animal model to study factors influencing regeneration and direct innervation or neurotization of skeletal muscle 116
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome 115
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 115
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 114
Dalla malattia di Schilder all’adrenoleucodistrofia; una breve storia di un secolo di ricerca neuropatologica clinica esemplare 114
La capacità rigenerativa del muscolo scheletrico danneggiato: studio sperimentale 114
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis 113
Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases 113
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders 113
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 112
Autoantibodies in multiple sclerosis patients before and during IFN-β1b treatment: Are they correlated with the occurrence of autoimmune diseases? 112
Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. 112
Migraine as possible red flag of PFO presence in suspected demyelinating disease 112
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 111
Histopathological heterogeneity and cytopathological similarity of findings in different muscles of two brothers affected by rigid spine syndrome 110
Are giant axons a pathological marker of charcot-marie-tooth neuropathy type 2E? 110
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 109
Prognostic indicators in pediatric clinically isolated syndrome 108
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 107
Progressive rubella panencephalitis. Follow-up EEG study of a case 107
Dalla malattia di Schilder alla adrenoleucodistrofia: una breve storia di un secolo di ricerca neuropatologica clinica esemplare 106
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 105
Monitoraggio biologico e sorveglianza sanitaria ai lavoratori esposti a bromuro di metile 105
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 105
Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease 104
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 104
Normative values of the brief international cognitive assessment for multiple sclerosis (BICAMS) in an Italian young adolescent population: the influence of age, sex, and education 104
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases 103
The Rise of the GRN C157KfsX97 Mutation in Southern Italy: Going Back to the Fall of the Western Roman Empire 103
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study 102
Totale 13.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/20221.067 52 132 10 27 292 9 27 34 37 68 97 282
2022/20232.026 171 36 32 185 240 179 2 134 923 20 60 44
2023/2024731 70 21 48 56 252 60 10 25 6 3 57 123
2024/20252.675 6 45 40 74 399 406 298 201 393 420 235 158
2025/202610.728 323 424 556 524 895 5.915 639 477 379 276 201 119
Totale 19.876